Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions
- PMID: 24248812
- PMCID: PMC3995140
- DOI: 10.1002/gepi.21771
Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions
Abstract
Genes that alter disease risk only in combination with certain environmental exposures may not be detected in genetic association analysis. By using methods accounting for gene-environment (G × E) interaction, we aimed to identify novel genetic loci associated with breast cancer risk. Up to 34,475 cases and 34,786 controls of European ancestry from up to 23 studies in the Breast Cancer Association Consortium were included. Overall, 71,527 single nucleotide polymorphisms (SNPs), enriched for association with breast cancer, were tested for interaction with 10 environmental risk factors using three recently proposed hybrid methods and a joint test of association and interaction. Analyses were adjusted for age, study, population stratification, and confounding factors as applicable. Three SNPs in two independent loci showed statistically significant association: SNPs rs10483028 and rs2242714 in perfect linkage disequilibrium on chromosome 21 and rs12197388 in ARID1B on chromosome 6. While rs12197388 was identified using the joint test with parity and with age at menarche (P-values = 3 × 10(-07)), the variants on chromosome 21 q22.12, which showed interaction with adult body mass index (BMI) in 8,891 postmenopausal women, were identified by all methods applied. SNP rs10483028 was associated with breast cancer in women with a BMI below 25 kg/m(2) (OR = 1.26, 95% CI 1.15-1.38) but not in women with a BMI of 30 kg/m(2) or higher (OR = 0.89, 95% CI 0.72-1.11, P for interaction = 3.2 × 10(-05)). Our findings confirm comparable power of the recent methods for detecting G × E interaction and the utility of using G × E interaction analyses to identify new susceptibility loci.
Keywords: body mass index; breast cancer risk; case-control study; gene-environment interaction; polymorphisms.
© 2013 WILEY PERIODICALS, INC.
Figures
References
-
- Bakken K, Fournier A, Lund E, Waaseth M, Dumeaux V, Clavel-Chapelon F, Fabre A, Hemon B, Rinaldi S, Chajes V. Menopausal hormone therapy and breast cancer risk: impact of different treatments. The European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2011;128(1):144–156. and others. - PubMed
-
- Bergström A, Pisani P, Tenet V, Wolk A, Adami HO. Overweight as an avoidable cause of cancer in Europe. Int J Cancer. 2001;91(3):421–430. - PubMed
Publication types
MeSH terms
Grants and funding
- U01 CA069417/CA/NCI NIH HHS/United States
- U01 CA069638/CA/NCI NIH HHS/United States
- CA128978/CA/NCI NIH HHS/United States
- U01 CA69417/CA/NCI NIH HHS/United States
- UM1 CA164920/CA/NCI NIH HHS/United States
- C490/A10119/CRUK_/Cancer Research UK/United Kingdom
- 16565/CRUK_/Cancer Research UK/United Kingdom
- BREAST CANCER NOW RESEARCH CENTRE/BBC_/Breast Cancer Now/United Kingdom
- 1U19 CA148537/CA/NCI NIH HHS/United States
- R01 CA128978/CA/NCI NIH HHS/United States
- C1287/A 10710/CRUK_/Cancer Research UK/United Kingdom
- U19 CA148537/CA/NCI NIH HHS/United States
- P50 CA116201/CA/NCI NIH HHS/United States
- C1287/A12014/CRUK_/Cancer Research UK/United Kingdom
- U01 CA164920/CA/NCI NIH HHS/United States
- U19 CA148065/CA/NCI NIH HHS/United States
- C1281/A12014/CRUK_/Cancer Research UK/United Kingdom
- 10118/CRUK_/Cancer Research UK/United Kingdom
- U01 CA069467/CA/NCI NIH HHS/United States
- RFA-CA-06-503/CA/NCI NIH HHS/United States
- 11022/CRUK_/Cancer Research UK/United Kingdom
- CAPMC/ CIHR/Canada
- C12292/A11174/CRUK_/Cancer Research UK/United Kingdom
- C8197/A10123/CRUK_/Cancer Research UK/United Kingdom
- 1U19 CA148065/CA/NCI NIH HHS/United States
- C5047/A10692/CRUK_/Cancer Research UK/United Kingdom
- C490/A10124/CRUK_/Cancer Research UK/United Kingdom
- C5047/A8384/CRUK_/Cancer Research UK/United Kingdom
- P30 CA015083/CA/NCI NIH HHS/United States
- C5047/A15007/CRUK_/Cancer Research UK/United Kingdom
- 16563/CRUK_/Cancer Research UK/United Kingdom
- U01 CA69638/CA/NCI NIH HHS/United States
- ImNIH/Intramural NIH HHS/United States
- 1U19 CA148112/CA/NCI NIH HHS/United States
- U19 CA148112/CA/NCI NIH HHS/United States
- C1287/A10118/CRUK_/Cancer Research UK/United Kingdom
- U01 CA69467/CA/NCI NIH HHS/United States
- 16561/CRUK_/Cancer Research UK/United Kingdom
- 10124/CRUK_/Cancer Research UK/United Kingdom
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases